Cervical smear plus HPV test at The London Breast Clinic
Cervical cancer have rarely, if ever, been screened. These women may not obtain pelvic examinations partly because of the cost. The use of liquid-based cytologic screening adds upfront costs, and, therefore, could lead to a paradoxical increase in mortality from this disease if this cost prevented more women from being screened. For example, most women in the United States who die from cervical cancer have rarely, if ever, been screened.